# Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)

> **NCT04574960** · PHASE3 · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 14 (estimated)

## Conditions studied

- Bladder Cancer
- Bladder Urothelial Carcinoma

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** Cisplatin
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT04574960
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-08
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2025-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04574960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04574960, "Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04574960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*